ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study
about
FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapyFluoropyrimidine ActivityPolymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations.Survival of distinct Asian groups among colorectal cancer cases in CaliforniaThymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancersPharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphismAnalysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer.Translational medicine and reliability of single-nucleotide polymorphism studies: can we believe in SNP reports or not?Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapy.Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer OutcomeAssociation of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population.Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patients.Polymorphisms of MTHFR C677T and A1298C associated with survival in patients with colorectal cancer treated with 5-fluorouracil-based chemotherapy.Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.PharmGKB summary: fluoropyrimidine pathwaysABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients.MTHFR gene polymorphisms and response to chemotherapy in colorectal cancer: a meta-analysis.Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy.The prognostic significance of APC gene mutation and miR-21 expression in advanced-stage colorectal cancer.EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function.APEX microarray panel for genotyping polymorphisms in cancer chemotherapy and estimation frequencies in a Slovak population.Relationship Between Expression of Proteins ERCC1, ERCC2, and XRCC1 and Clinical Outcomes in Patients with Rectal Cancer Treated with FOLFOX-Based Preoperative Chemoradiotherapy.The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates Colorectal Carcinogenesis and Prognosis.Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine.
P2860
Q26851060-D0AA41C0-6469-4BCF-8E98-00358810B349Q29883401-ED3BD9B4-6860-4C94-88BF-DA55F3DCCC0CQ33648490-716968CE-E587-40E1-8D3D-17E2095DAFC8Q33703793-B195CCD1-4F5D-4128-92CB-61A0CD2C1480Q34214957-A81514FE-E2D4-4EAB-8F6F-214A4ECB4052Q34429411-2928B0BE-61C1-45D6-A442-31ED2AF50C78Q35167868-AF74C656-9DF1-4450-9919-819549AF64B8Q35196724-2793CCE6-FFAB-40E2-B109-4C6936954302Q36117701-95174A64-295B-44A6-B931-DE20100C90ECQ36656187-E7566658-4389-4BF1-A6E3-EC69ECA4E602Q37587471-DDBF5DA1-0A21-4023-AA41-DB3152B6C916Q38835268-683DEDB3-24F9-48FD-93C1-C05FE9C0B4D8Q39043677-B568207B-B036-41E3-88A1-4351E454E7CEQ40582133-E9028E0B-5367-40D9-9919-4E2871D94317Q42178970-411BB177-52AF-4DD3-BB0E-8C8AFD89751BQ42782251-E20B9665-FC06-403E-8DF8-A284DBB23266Q43296440-C6C57460-91EE-4412-AD89-5159A2638251Q43452895-381F70D8-7A19-4837-9A05-0B7604B5F496Q43521742-605EB3AB-76C8-4EA0-A8EB-9DAED21F4B42Q49569642-D69FD5D6-31DE-44B0-B98E-268F01F53602Q50108965-758520EB-8684-44C8-913A-77346D01A432Q50947717-C53AED7A-FBC0-4F87-BF71-8624D94CF4DCQ52641380-DEF8A1B0-BCC9-466B-9F33-C44AD4EEFCAFQ54494355-911EA92B-14E6-4ABA-AD5A-F71D37BD8606
P2860
ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@ast
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@en
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@en-gb
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@nl
type
label
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@ast
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@en
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@en-gb
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@nl
altLabel
ERCC22251A>C genetic polymorph ...... patients: A preliminary study
@en
prefLabel
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@ast
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@en
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@en-gb
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@nl
P2093
P2860
P356
P1433
P1476
ERCC2 2251A>C genetic polymorp ...... patients: a preliminary study
@en
P2093
Jaw-Yuan Wang
Ming-Yii Huang
Shiu-Ru Lin
Su-Chen Lee
Wei-Yu Fang
P2860
P2888
P356
10.1186/1471-2407-8-50
P407
P577
2008-02-12T00:00:00Z
P5875
P6179
1032746484